Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06394570
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2024-04-27
Brief Title:
Enfortumab Vedotin and Stereotactic Radiation for Localized Cisplatin Ineligible Muscle Invasive Bladder Cancer
Sponsor:
University of Texas Southwestern Medical Center
Organization:
University of Texas Southwestern Medical Center
Organization Data
Organization:
University of Texas Southwestern Medical Center
Class:
OTHER
Study ID:
STU-2024-0374
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Texas Southwestern Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Tian Zhang
Responsible Party Title:
Associate Professor- Internal Medicine
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Texas Southwestern Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Astellas Pharma Inc | INDUSTRY |